Evernow Publishing Ltd is a life science publisher specialising in journals and reports about the pharmaceutical industry. Its main product is MedNous, a business journal about medical innovation
Evernow is publishing a new report on the regulation of stem cell and gene therapies, and tissue-engineered products in Europe. Written by regulatory experts at the ERA Consulting Group, this authoritative report explains in detail what developers need to know in applying for a marketing authorisation in Europe.
This report is essential reading for anyone engaged in developing advanced therapy medicinal products (ATMPs), or anyone giving advice to developers. This applies to universities, hospitals, small and medium-sized enterprises, specialty pharma, big pharma, regulatory consultancies and law firms.
Reserve your copy now: Please send an email to [email protected]
A single copy of An Introduction to the European Regulatory Pathway for Advanced Therapy Medicinal Products is £199 or €252 or $324.Multiple copies can be obtained at a discount: 25% off for two or three copies; 50% off the list price for four or more copies.
Multiple copies can be obtained for a discount
10x per year journal and website.
Annual subscription: £299
All purchasers of Evernow Publishing products have the right to cancel their orders within seven days of purchase, or within seven days of receipt of the goods, which ever is longer. Purchasers who do cancel will have their payments returned by way of a bank transfer or cheque following notification.
Evernow Publishing Ltd, registered in Companies House, Cardiff, Wales.
Postal address: 39 Calabria Road, London N5 1HZ
Registered office: 39 Calabria Road, London N5 1HZ
Registration number: 6019186
Telephone: +44 (0) 20 7704 1015
Email: [email protected]